Page last updated: 2024-12-07

uridylyl-(3'-5')-adenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Uridylyl-(3'-5')-adenosine, also known as UpA, is a dinucleotide composed of uridine monophosphate (UMP) linked to adenosine monophosphate (AMP) via a 3'-5' phosphodiester bond. It is a fundamental building block of RNA and plays a crucial role in various cellular processes. UpA is involved in the synthesis of RNA, serving as a substrate for RNA polymerase. It also acts as a messenger molecule in signaling pathways, influencing gene expression. Moreover, UpA has been implicated in the regulation of cell growth and development. Researchers study UpA to understand its role in RNA synthesis, cellular signaling, and other biological processes. They investigate its interaction with enzymes, its impact on gene expression, and its potential as a therapeutic target.'

Cross-References

ID SourceID
PubMed CID92951
SCHEMBL ID8613078
MeSH IDM0054489

Synonyms (10)

Synonym
adenosine, uridylyl-(3'-5')-
uridylyl(3'.5')adenosine
uridylyl-(3'-5')-adenosine
uridyladenosine
upa dinucleotide
einecs 221-852-1
nsc 118092
SCHEMBL8613078
DTXSID101311037
uridylyl-(3'-->5')-adenosine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
nucleoside analogueAn analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells.
purinesA class of imidazopyrimidines that consists of purine and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.00)18.7374
1990's6 (30.00)18.2507
2000's2 (10.00)29.6817
2010's9 (45.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.24 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]